ShareValue scores for EMBC: Valuation 71, Quality 60, Growth 40, Health 38.
EMBCNASDAQ
Embecta Corp
$3.50
(-1.96%)
EMBCNASDAQ
Embecta Corp
$3.50(-1.96%)
Loading chart...
Sentiment
Verdicts
Value:Undervalued
Quality:Moderate
Growth:Moderate
Health:Stressed
Verdicts
Fundamental Rating
Value Trap Risk
Expected Return
11% to 27%
Rating
Trap Risk
Return
11% to 27%
Valuation
71
Undervalued
Price vs Value
Quality
60
Moderate
Business Strength
Growth
40
Moderate
Revenue & Earnings
Health
38
Stressed
Financial Stability
Momentum
14
Bearish
Price Trend
Company Details
About
Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
Market Cap$208M
P/E Ratio1.8
Dividend Yield17.80%
Sector Rank#1277
Score Analysis
AI Investment Thesis
Data as of:Aug 7, 2026
|Last calculated:Aug 7, 2026